VANCOUVER, British Columbia, May 19, 2021 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. ("Bearclaw" or the "Company"} (NEX: BRL.H} announces that Mohan R. Vulimiri has resigned as a director of the...
VANCOUVER, British Columbia, April 22, 2021 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the “Company”) (NEX:BRL.H) is pleased to announce the appointment of Connie Hang as the...
VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the “Company”) (NEX:BRL.H) is pleased to announce a non-brokered private placement for up to...
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the “Company”) (NEX:BRL.H) is pleased to announce a non-brokered private placement for up to...
VANCOUVER, British Columbia, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the “Company”) (TSX Venture Exchange: BRL.H) is pleased to announce that the TSX Venture...
VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (“Bearclaw” or the “Company”) (TSX Venture Exchange: BRL.H) is pleased to announce that it has mailed the...
VANCOUVER, British Columbia, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Bearclaw Capital Corp. (TSX-V: BRL.H) (the “Company”) announces that effective February 13, 2020 the listing of the Company’s...
VANCOUVER, B.C., July 10, 2017 (GLOBE NEWSWIRE) -- Prism Resources Inc. (TSX.V:PRS) (the “Company”) announces that it has entered into an agreement with AuRico Metals Inc. and AuRico Metals...
MONTVALE, N.J., Nov. 26 /PRNewswire/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by...
MONTVALE, N.J., March 28 /PRNewswire/ -- Christine A. Mundkur, Esq. Chief Executive Officer, Barr Laboratories, Inc. -- In this newly created position, Mundkur has responsibility for...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales